Level Four Advisory Services’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$565K Buy
6,813
+50
+0.7% +$4.15K 0.02% 489
2025
Q1
$548K Buy
6,763
+639
+10% +$51.8K 0.02% 478
2024
Q4
$552K Sell
6,124
-223
-4% -$20.1K 0.02% 470
2024
Q3
$616K Sell
6,347
-325
-5% -$31.5K 0.03% 460
2024
Q2
$619K Sell
6,672
-878
-12% -$81.4K 0.03% 435
2024
Q1
$674K Hold
7,550
0.04% 380
2023
Q4
$674K Sell
7,550
-906
-11% -$80.9K 0.04% 377
2023
Q3
$617K Buy
8,456
+795
+10% +$58.1K 0.04% 386
2023
Q2
$637K Buy
7,661
+622
+9% +$51.8K 0.04% 404
2023
Q1
$536K Sell
7,039
-63
-0.9% -$4.8K 0.04% 408
2022
Q4
$589K Buy
7,102
+508
+8% +$42.2K 0.04% 360
2022
Q3
$523K Buy
6,594
+52
+0.8% +$4.12K 0.05% 305
2022
Q2
$486K Sell
6,542
-231
-3% -$17.2K 0.05% 340
2022
Q1
$609K Sell
6,773
-1,376
-17% -$124K 0.05% 341
2021
Q4
$912K Buy
8,149
+301
+4% +$33.7K 0.07% 272
2021
Q3
$987K Sell
7,848
-20,377
-72% -$2.56M 0.1% 192
2021
Q2
$3.82M Buy
28,225
+1,980
+8% +$268K 0.26% 96
2021
Q1
$3.56M Buy
26,245
+62
+0.2% +$8.41K 0.28% 93
2020
Q4
$3.69M Sell
26,183
-10,717
-29% -$1.51M 0.3% 88
2020
Q3
$4.11M Sell
36,900
-1,050
-3% -$117K 0.32% 73
2020
Q2
$4.24M Buy
37,950
+13,179
+53% +$1.47M 0.33% 72
2020
Q1
$1.92M Buy
24,771
+16,537
+201% +$1.28M 0.23% 112
2019
Q4
$1.21M Buy
8,234
+11
+0.1% +$1.62K 0.05% 255
2019
Q3
$627K Buy
8,223
+429
+6% +$32.7K 0.06% 288
2019
Q2
$684K Sell
7,794
-1,183
-13% -$104K 0.07% 265
2019
Q1
$813K Buy
8,977
+1,796
+25% +$163K 0.09% 226
2018
Q4
$515K Sell
7,181
-2,528
-26% -$181K 0.06% 289
2018
Q3
$931K Sell
9,709
-5,239
-35% -$502K 0.1% 206
2018
Q2
$1.42M Buy
14,948
+1,289
+9% +$123K 0.1% 188
2018
Q1
$1.2M Buy
13,659
+724
+6% +$63.5K 0.09% 199
2017
Q4
$1.1M Buy
12,935
+370
+3% +$31.4K 0.09% 213
2017
Q3
$1.09M Buy
12,565
+3,189
+34% +$276K 0.1% 199
2017
Q2
$628K Hold
9,376
0.1% 213
2017
Q1
$628K Buy
9,376
+4,347
+86% +$291K 0.06% 276
2016
Q4
$298K Buy
+5,029
New +$298K 0.04% 364